US6498017B2
(en)
|
1907-11-28 |
2002-12-24 |
Evotec Biosystems Ag |
Method for measuring the association of substructures of pathological protein depositions
|
ATE177754T1
(en)
|
1991-12-03 |
1999-04-15 |
Proteus Molecular Design |
FRAGMENTS OF PRION PROTEINS.
|
WO1997010505A1
(en)
|
1995-09-14 |
1997-03-20 |
The Regents Of The University Of California |
ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿
|
US5750361A
(en)
*
|
1995-11-02 |
1998-05-12 |
The Regents Of The University Of California |
Formation and use of prion protein (PRP) complexes
|
NZ332132A
(en)
*
|
1996-04-03 |
2000-02-28 |
Stichting Inst Voor Dierhouder |
Pre-clinical detection of prion diseases such as PrPsc
|
EP0914614B1
(en)
*
|
1996-05-14 |
2003-09-03 |
Winnacker, Ernst-Ludwig, Prof. |
CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc
|
US5834593A
(en)
*
|
1996-11-05 |
1998-11-10 |
The Regents Of The University Of California |
Soluble form of PrPSC which is insoluble in native form
|
GB2319607A
(en)
*
|
1996-11-23 |
1998-05-27 |
Electrophoretics International |
Detection of prion proteins in mononuclear cells
|
FR2758337B1
(en)
|
1997-01-14 |
1999-03-05 |
Commissariat Energie Atomique |
METHOD FOR SCREENING SUBSTANCES WITH THERAPEUTIC ACTION IN THE TREATMENT OF TSE COMPRISING A STEP FOR ISOLATING PRPRES, FROM THE SPLEEN, METHOD FOR ISOLATING PRPRES AND ITS APPLICATIONS
|
US6221614B1
(en)
*
|
1997-02-21 |
2001-04-24 |
The Regents Of The University Of California |
Removal of prions from blood, plasma and other liquids
|
US6720355B2
(en)
|
1997-02-21 |
2004-04-13 |
The Regents Of The University Of California |
Sodium dodecyl sulfate compositions for inactivating prions
|
US6620629B1
(en)
|
1997-02-21 |
2003-09-16 |
The Regents Of The University Of California |
Method for detecting prions
|
US6719988B2
(en)
|
1997-02-21 |
2004-04-13 |
The Regents Of The University Of California |
Antiseptic compositions for inactivating prions
|
EP0861900A1
(en)
*
|
1997-02-21 |
1998-09-02 |
Erziehungsdirektion Of The Canton Zurich |
Immunological detection of prions
|
US5891641A
(en)
*
|
1997-02-21 |
1999-04-06 |
The Regents Of The University Of California |
Assay for disease related conformation of a protein
|
US6617119B2
(en)
|
1997-02-21 |
2003-09-09 |
The Regents Of The University Of California |
Assay for specific strains of multiple disease related conformations of a protein
|
DE19730132C2
(en)
*
|
1997-07-14 |
2000-01-20 |
Fraunhofer Ges Forschung |
Method for the detection of prions and an apparatus therefor
|
DE19741607A1
(en)
*
|
1997-09-20 |
1999-03-25 |
Prionics Ag |
New polypeptides comprising prion protein sequences
|
DE1057022T1
(en)
*
|
1998-02-20 |
2001-10-25 |
Univ California |
ASSAY FOR SPECIFIC STRAINS OF PROTEIN INFORMATION RELATED TO SEVERAL DISEASES
|
GB2348203B
(en)
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Solube beta-forms of prion proteins, methods of preparation and use
|
FI982481A0
(en)
*
|
1998-11-17 |
1998-11-17 |
Wallac Oy |
Immunoassay for the detection of infectious bovine spongiform encephalopathy
|
FI982480A0
(en)
*
|
1998-11-17 |
1998-11-17 |
Wallac Oy |
Immunoassay for the detection of infectious spongiform encephalopathy in mammals
|
CA2364686C
(en)
|
1999-02-11 |
2007-04-24 |
Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. |
Prion test
|
GB2346971B
(en)
*
|
1999-02-19 |
2004-07-21 |
Audrey Ann Coop |
Blood test for infectious prion protein using antibodies raised to eye lens crystallin proteins
|
CA2377648A1
(en)
*
|
1999-06-23 |
2000-12-28 |
Caprion Pharmaceuticals, Inc. |
Prion protein peptides and uses thereof
|
US7041807B1
(en)
|
1999-06-23 |
2006-05-09 |
Caprion Pharmaceuticals, Inc. |
Antibodies to a YYX epitope of a mammalian prion protein
|
EP1210110A4
(en)
*
|
1999-06-29 |
2003-03-19 |
Univ Mcgill |
Prion protein binding proteins and uses thereof
|
WO2001077687A2
(en)
*
|
2000-04-05 |
2001-10-18 |
V.I Technologies, Inc. |
Prion-binding peptidic ligands and methods of using same
|
IL141950A0
(en)
*
|
2000-10-22 |
2002-03-10 |
Hadasit Med Res Service |
Diagnosis of prion diseases
|
EP1572894B1
(en)
|
2001-11-21 |
2016-04-13 |
New York University |
Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
|
US20040072236A1
(en)
|
2002-09-27 |
2004-04-15 |
Neil Cashman |
PrPSc -interacting molecules and uses thereof
|
EP1437144A1
(en)
*
|
2003-01-09 |
2004-07-14 |
IVPT Gmbh |
Rapid in-vivo test for Transmissible Spongiform Encephalopathy in the eye
|
WO2005016127A2
(en)
|
2003-08-13 |
2005-02-24 |
Chiron Corporation |
Prion-specific peptide reagents
|
GB0416699D0
(en)
|
2004-07-27 |
2004-09-01 |
Prometic Biosciences Ltd |
Prion protein ligands and methods of use
|
WO2006131768A2
(en)
|
2005-06-10 |
2006-12-14 |
Prometic Biosciences Limited |
Triazines as protein binding ligands
|
NZ566020A
(en)
|
2005-09-09 |
2012-08-31 |
Novartis Ag |
Prion-specific peptoid reagents
|
US8906382B2
(en)
|
2011-07-19 |
2014-12-09 |
New York University |
Method for treating amyloid disease
|
WO2013012811A2
(en)
|
2011-07-19 |
2013-01-24 |
New York University |
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
|